A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)

NCT03606057 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-64565111
DRUG: Moxifloxacin
DRUG: JNJ-64565111-matching Placebo
DRUG: Moxifloxacin-matching Placebo

Sponsor

Janssen Research & Development, LLC